← Feed

Hayden Michael R

SEC Form 4 insider
AbCellera Biologics Inc. ($ABCL)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ABCLSEC Form 4bullish
Hayden Michael R · AbCellera Biologics Inc. · 4h agono track record yet
Long 46,387 shares of ABCL
Bought 46,387 @ $10.37 avg · $481,033 · 2026-08-12

Form 4: Hayden Michael R bought ABCL

Hayden Michael R (Director at AbCellera Biologics Inc.) reported an open-market purchase of 46,387 shares of ABCL at an average $10.37, roughly $481,033, in a Form 4 filed 2026-08-14.

Now $11.421m ago
View filing on SEC.gov →

End of results.